Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment

Sponsor
Kessler Foundation (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02020564
Collaborator
(none)
80
1
2
120.6
0.7

Study Details

Study Description

Brief Summary

The purpose of this research study is to investigate the effectiveness of a technique designed to improve processing speed (i.e. the amount of time it takes to process information) in a Traumatic Brain Injury (TBI) population. The study is designed to study how well this technique can help people with TBI increase their processing speed and their ability to function better in everyday life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Speed of Processing Training
  • Behavioral: Placebo Control
N/A

Detailed Description

The current proposal is designed to apply this treatment protocol to a large sample of individuals with moderate to severe TBI with documented impairment in PS. The goals of the trial are to (a) test the efficacy of this treatment protocol within a TBI population, (b) evaluate the impact of the treatment on everyday functioning, (c) evaluate the longer-term efficacy of the treatment, and (d) examine the utility of booster sessions in facilitating longer-term treatment effects. Individuals with moderate to severe TBI, with documented impairment in PS, will be randomly assigned to a treatment group or a control group. Both groups will undergo baseline, immediate post-treatment and long-term follow-up assessment consisting of: (1) a standardized neuropsychological battery and (2) an assessment of global functioning examining the impact of the treatment on daily activities. This design will allow us to assess the efficacy of SPT in persons with TBI and evaluate its impact on everyday life.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment: A Randomized Clinical Trial
Actual Study Start Date :
Dec 12, 2012
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment Group

Computerized exercised will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).

Behavioral: Speed of Processing Training

Placebo Comparator: Placebo control group

Computerized exercises will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).

Behavioral: Placebo Control

Outcome Measures

Primary Outcome Measures

  1. Symbol-Digit Modalities Test [Baseline (week 1), immediately post-intervention (week 7) and 3 months post-intervention]

    Change in scores on standardized neuropsychological tests of Processing Speed using Symbol-Digit Modalities Test

Secondary Outcome Measures

  1. TBI Quality of Life, Depression scale [Baseline (week 1), immediately post-intervention (week 7) and 3 months post-intervention]

    Change in scores on self-report of emotional functioning, measured via questionnaire. The TBI QOL Depression scale measures depression. The range is 1-40. A higher score indicates greater depression.

  2. Perceived Deficits Questionnaire [Baseline (week 1), immediately post-intervention (week 7) and 3 months post-intervention]

    Change in scores on self-report of perceived cognitive deficits in daily life, measured via questionnaire. A higher score indicates greater perceived deficits in daily life. Range of scores on the scale is 0-80.

  3. TBI Quality of Life, Total Score [Baseline (week 1), immediately post-intervention (week 7) and 3 months post-intervention]

    Change in scores on self-report of quality of life, measured via questionnaire. DV is the TBI-QOL total score. The range is 1-40. A higher score indicates better quality of life.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 59 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • diagnosis of Traumatic Brain Injury or Mild cognitive impairment

  • Fluent in English

  • processing speed impairment

Exclusion Criteria:
  • prior stroke or neurological disease

  • currently taking steroids and/or benzodiazepines

  • history of significant pyschiatric illness (for example, bipolar disorder, schizophrenia, or pyschosis) or a current diagnosis of Major Depressive Disorder, Schizophrenia, Epilepsy, Bipolar Disorder

  • significant alcohol or drug abuse history

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kessler Foundation East Hanover New Jersey United States 07936

Sponsors and Collaborators

  • Kessler Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nancy Chiaravalloti, Director, Neuropsychology & Neuroscience; Director, Traumatic Brain Injury Research, Kessler Foundation
ClinicalTrials.gov Identifier:
NCT02020564
Other Study ID Numbers:
  • R-755-12
First Posted:
Dec 25, 2013
Last Update Posted:
Sep 30, 2021
Last Verified:
Sep 1, 2021
Keywords provided by Nancy Chiaravalloti, Director, Neuropsychology & Neuroscience; Director, Traumatic Brain Injury Research, Kessler Foundation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 30, 2021